Edition:
United States

Anika Therapeutics Inc (ANIK.OQ)

ANIK.OQ on NASDAQ Stock Exchange Global Select Market

40.31USD
25 May 2018
Change (% chg)

$-1.10 (-2.66%)
Prev Close
$41.41
Open
$41.42
Day's High
$41.45
Day's Low
$40.29
Volume
52,298
Avg. Vol
50,626
52-wk High
$68.57
52-wk Low
$31.00

Select another date:

Wed, May 23 2018

BRIEF-Anika Therapeutics Announces $30 Mln Accelerated Share Repurchase

* ANIKA THERAPEUTICS ANNOUNCES $30 MILLION ACCELERATED SHARE REPURCHASE

BRIEF-Anika Therapeutics Q1 Loss Per Share $0.46

* Q1 EARNINGS PER SHARE VIEW $0.16 -- THOMSON REUTERS I/B/E/S

BRIEF-Joseph Darling Named CEO And Director Of Anika Therapeutics

* JOSEPH DARLING NAMED CEO AND DIRECTOR OF ANIKA THERAPEUTICS

BRIEF-Anika Q4 Earnings Per Share $0.53

* ANIKA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Anika Therapeutics Announces Strategic Collaboration With The Institute Of Integrative Biology

* ANIKA THERAPEUTICS ANNOUNCES STRATEGIC COLLABORATION WITH THE INSTITUTE OF INTEGRATIVE BIOLOGY AT THE UNIVERSITY OF LIVERPOOL TO DEVELOP AN INNOVATIVE THERAPY FOR OSTEOARTHRITIS Source text for Eikon: Further company coverage:

BRIEF-Anika Therapeutics Expands Strategic Collaboration With Institute For Applied Life Sciences

* ANIKA THERAPEUTICS EXPANDS STRATEGIC COLLABORATION WITH THE INSTITUTE FOR APPLIED LIFE SCIENCES (IALS) AT THE UNIVERSITY OF MASSACHUSETTS AMHERST TO DEVELOP INNOVATIVE THERAPY FOR RHEUMATOID ARTHRITIS Source text for Eikon: Further company coverage:

BRIEF-Anika Announces FDA 510(K) Clearance For Its Injectable HA-Based Bone Repair Treatment

* ANIKA ANNOUNCES FDA 510(K) CLEARANCE FOR ITS INJECTABLE HA-BASED BONE REPAIR TREATMENT

Select another date: